This inventor holds 1 USPTO granted patent and 1 published patent application and 1 EPO patent. Top assignee: Genentech, Inc.. Active years: 2021.
Company Filing History:
Years Active: 2021
Title: Lina Han - Innovator in Cancer Treatment
Introduction
Lina Han is a prominent inventor based in Houston, TX (US), known for her significant contributions to cancer treatment. She has developed innovative therapies that aim to improve patient outcomes in oncology. Her work is particularly focused on combining targeted therapies to enhance treatment efficacy.
Latest Patents
Lina Han holds a patent for a groundbreaking invention titled "Combination of Bcl-2 inhibitor and MEK inhibitor for the treatment of cancer." This patent describes a combination therapy that involves a selective Bcl-2 inhibitor and a MEK inhibitor, specifically designed for patients suffering from cancer, such as acute myeloid leukemia. This innovative approach aims to provide a more effective treatment option for those in need.
Career Highlights
Throughout her career, Lina has worked with notable organizations, including Genentech, Inc. and The University of Texas System. Her experience in these esteemed institutions has allowed her to collaborate with leading experts in the field of cancer research and treatment.
Collaborations
Lina has had the opportunity to work alongside talented colleagues, including Marina Konopleva and Mark Merchant. These collaborations have further enriched her research and contributed to her success as an inventor.
Conclusion
Lina Han's innovative work in cancer treatment exemplifies the impact of combining targeted therapies to improve patient care. Her contributions to the field are invaluable, and her patent reflects her commitment to advancing medical science.